Data is not available at this time.
Elis SA operates as a leading provider of linen, workwear, hygiene, and well-being services across Europe and Latin America, serving sectors such as catering, healthcare, retail, and public administration. The company’s core revenue model is built on rental and maintenance services for textiles and hygiene products, ensuring recurring revenue streams through long-term contracts. Elis differentiates itself through sustainability initiatives, offering reusable solutions that reduce environmental impact while maintaining high service quality. Its diversified portfolio includes table linens, industrial wipers, medical waste management, and cleanroom garments, catering to both B2B and institutional clients. The company holds a strong market position in France and the UK, with expanding footprints in Scandinavia and Latin America. Competitive advantages include economies of scale, integrated logistics, and a focus on innovation in hygiene and safety solutions. Elis leverages its pan-European infrastructure to deliver cost-efficient services, reinforcing its leadership in the fragmented textile rental and hygiene services industry.
Elis reported revenue of EUR 4.57 billion for the latest fiscal year, with net income of EUR 337.8 million, reflecting a steady operational performance. The company’s operating cash flow of EUR 1.45 billion underscores its ability to convert sales into cash efficiently, while capital expenditures of EUR 860.8 million indicate ongoing investments in service infrastructure and sustainability initiatives. Diluted EPS stood at EUR 1.30, demonstrating consistent profitability.
Elis generates robust earnings power, supported by its asset-light rental model and high customer retention rates. The company’s capital efficiency is evident in its ability to maintain profitability while expanding its service footprint. Operating cash flow covers debt obligations comfortably, and reinvestment in capex aligns with growth in high-margin segments like healthcare and cleanroom solutions.
Elis maintains a solid balance sheet with EUR 622.1 million in cash and equivalents, though total debt of EUR 4.26 billion reflects its acquisitive growth strategy. The company’s leverage is manageable given its stable cash flows, and liquidity remains sufficient to meet short-term obligations. Debt is primarily used to fund expansion and operational scalability.
Elis has demonstrated consistent growth through organic expansion and strategic acquisitions, particularly in hygiene and medical services. The company pays a dividend of EUR 0.43 per share, reflecting a balanced approach to shareholder returns and reinvestment. Future growth is expected to be driven by demand for outsourced hygiene solutions and sustainability-focused services.
With a market capitalization of EUR 5.54 billion and a beta of 1.53, Elis is viewed as a moderately volatile stock with growth potential. Investors likely price in its defensive qualities, given its recession-resistant business model, alongside expectations for margin improvement in international markets.
Elis benefits from its entrenched market position, diversified service offerings, and focus on sustainability. The outlook remains positive, supported by structural demand for hygiene services and cross-selling opportunities in newer markets. Risks include exposure to economic cycles in hospitality and healthcare, but long-term contracts provide revenue visibility.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |